Facilities

Mission
Enhance Hong Kong's clinical trial capacity and efficiency, to develop Hong Kong into an international health and medical innovation hub.
Strategic Location
-
Hong Kong
One Country and Two Systems, Strong Support of the Motherland, Closely Connected to the World.
-
Hetao area
One Zone, Two Parks, Technological Innovation, Institutional Innovation, Cross-boundary Facilitation.
-
Guangdong-Hong Kong-Macao Greater Bay Area (GBA)
Population Over 86 Million, Special Measures of Using HK Registered Drugs and Medical Devices Used in HK Public Hospitals in GBA.

Our Management

Prof. Bernard M. Y. Cheung
GBAICTI Chief Executive Officer
MA, MB BChir (Cantab), PhD (Cantab), FRCP (Edin). FRCP (Lond), FHKCP, FHKAM (Medicine), FBHS, FBPhS
Governance
-
Wholly owned by the Government
-
All directors appointed by the Secretary for Health
-
Operated by the LKS Faculty of Medicine of The University of Hong Kong.

